
Replimune Group
(NASDAQ) REPL
Replimune Group Financials at a Glance
Market Cap
$933.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$313.94M
EPS (TTM)
-$3.51
P/E Ratio
-3.17
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$11.12
Volume
2,744,923
Open
$11.18
Price
$11.12
Volume
2,744,923
Open
$11.18
Previous Close
$11.11
Daily Range
$10.90 - $11.32
52-Week Range
$1.50 - $13.24
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$11.12
Volume
2,744,923
Open
$11.18
Previous Close
$11.11
Daily Range
$10.90 - $11.32
52-Week Range
$1.50 - $13.24
Estimated Earnings Date
Aug 6, 2026
REPL News
REPL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Replimune Group
Industry
Biotechnology
Sector
Health CareEmployees
465
CEO
Sushil Patel, PhD
Website
www.replimune.comHeadquarters
Woburn, MA 01801, US
REPL Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-128.57%
Return on Capital
-164.54%
Return on Assets
-94.45%
Earnings Yield
-31.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$933.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
83.95M
Volume
2.74M
Avg. Volume
7.83M
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$319.92M
EBITDA
-$314.49M
Operating Cash Flow
-$280.34M
Capital Expenditure
-$4.22M
Free Cash Flow
-$284.57M
Cash & ST Invst.
$268.89M
Total Debt
$28.28M
Replimune Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$933.47MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.95M
N/A
Employees
479
N/A
Net Income
-$73.22M
+1.2%
EBITDA
-$75.07M
-4.3%
Quarterly Fundamentals
Total Cash
$268.89M
-44.4%
Total Debt
$28.28M
-62.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$24.24M
-66.4%
Short Term Debt
$4.04M
+1.5%
Return on Assets
-94.45%
N/A
Return on Invested Capital
-1.17%
N/A
Free Cash Flow
-$56.17M
-2.4%
Operating Cash Flow
-$56.16M
-4.5%






